MetLife Investment Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
14,631
+2,424
| +20% | +$23.2K | ﹤0.01% | 2374 |
|
|
2025
Q1 | $114K | Hold |
12,207
| – | – | ﹤0.01% | 2469 |
|
|
2024
Q4 | $170K | Hold |
12,207
| – | – | ﹤0.01% | 2380 |
|
|
2024
Q3 | $287K | Hold |
12,207
| – | – | ﹤0.01% | 2089 |
|
|
2024
Q2 | $195K | Buy |
12,207
+4,505
| +58% | +$72K | ﹤0.01% | 2260 |
|
|
2024
Q1 | $126K | Hold |
7,702
| – | – | ﹤0.01% | 2432 |
|
|
2023
Q4 | $107K | Hold |
7,702
| – | – | ﹤0.01% | 2583 |
|
|
2023
Q3 | $106K | Hold |
7,702
| – | – | ﹤0.01% | 2552 |
|
|
2023
Q2 | $131K | Hold |
7,702
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q1 | $124K | Buy |
+7,702
| New | +$124K | ﹤0.01% | 2463 |
|